191 related articles for article (PubMed ID: 36865417)
1. The Association of Human Leukocyte Antigens Complex with Type 1 Diabetes in the Omani Population.
Al-Balushi M; Al-Badi S; Al-Yaarubi S; Al-Riyami H; Al-Shidhani A; Al-Hinai S; Alshirawi A; Hasson S; Said E; Al-Jabri A; Al Ansari A
Sultan Qaboos Univ Med J; 2023 Feb; 23(1):68-75. PubMed ID: 36865417
[TBL] [Abstract][Full Text] [Related]
2. The influence of the HLA-DRB, HLA-DQB and polymorphic positions of the HLA-DRβ1 and HLA-DQβ1 molecules on risk of Iranian type 1 diabetes mellitus patients.
Sayad A; Akbari MT; Pajouhi M; Mostafavi F; Zamani M
Int J Immunogenet; 2012 Oct; 39(5):429-36. PubMed ID: 22494469
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA-DRB1 and -DQ Alleles and Haplotypes with Type 1 Diabetes in Jordanians.
Khdair SI; Jarrar W; Jarrar YB; Bataineh S; Al-Khaldi O
Endocr Metab Immune Disord Drug Targets; 2020; 20(6):895-902. PubMed ID: 31742498
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune type 1 diabetes genetic susceptibility encoded by human leukocyte antigen DRB1 and DQB1 genes in Tunisia.
Stayoussef M; Benmansour J; Al-Irhayim AQ; Said HB; Rayana CB; Mahjoub T; Almawi WY
Clin Vaccine Immunol; 2009 Aug; 16(8):1146-50. PubMed ID: 19553558
[TBL] [Abstract][Full Text] [Related]
5. The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes.
Battelino T; Ursic-Bratina N; Dolzan V; Stopar-Obreza M; Pozzilli P; Krzisnik C; Vidan-Jeras B
Eur J Immunogenet; 2003 Jun; 30(3):223-7. PubMed ID: 12787001
[TBL] [Abstract][Full Text] [Related]
6. Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs.
Al-Jenaidi FA; Wakim-Ghorayeb SF; Al-Abbasi A; Arekat MR; Irani-Hakime N; Najm P; Al-Ola K; Motala AA; Almawi WY
J Clin Endocrinol Metab; 2005 Sep; 90(9):5104-9. PubMed ID: 15985473
[TBL] [Abstract][Full Text] [Related]
7. HLA-DRB, -DQA, and DQB alleles and haplotypes in Iranian patients with diabetes mellitus type I.
Rabbani A; Abbasi F; Taghvaei M; Rabbani B; Moradi B; Shakiba Y; Rezaei N; Amirzargar A
Pediatr Diabetes; 2013 Aug; 14(5):366-71. PubMed ID: 22583516
[TBL] [Abstract][Full Text] [Related]
8. HLA class II susceptibility pattern for type 1 diabetes (T1D) in an Iranian population.
Kiani J; Hajilooi M; Furst D; Rezaei H; Shahryari-Hesami S; Kowsarifard S; Zamani A; Solgi G
Int J Immunogenet; 2015 Aug; 42(4):279-86. PubMed ID: 26088816
[TBL] [Abstract][Full Text] [Related]
9. Family-based association study of HLA class II with type 1 diabetes in Moroccans.
Drissi Bourhanbour A; Benseffaj N; Ouadghiri S; Razine R; Touzani A; Belafraj A; Essakalli M
Pathol Biol (Paris); 2015 Apr; 63(2):80-4. PubMed ID: 25555495
[TBL] [Abstract][Full Text] [Related]
10. Effect of human leukocyte antigen class II genes on acute-onset and slow-onset type 1 diabetes in the Japanese population.
Katahira M; Segawa S; Maeda H; Yasuda Y
Hum Immunol; 2010 Aug; 71(8):789-94. PubMed ID: 20510319
[TBL] [Abstract][Full Text] [Related]
11. Association between alleles, haplotypes, and amino acid variations in HLA class II genes and type 1 diabetes in Kuwaiti children.
Dashti M; Nizam R; Jacob S; Al-Kandari H; Al Ozairi E; Thanaraj TA; Al-Mulla F
Front Immunol; 2023; 14():1238269. PubMed ID: 37638053
[TBL] [Abstract][Full Text] [Related]
12. HLA Genetic Discrepancy Between Latent Autoimmune Diabetes in Adults and Type 1 Diabetes: LADA China Study No. 6.
Luo S; Lin J; Xie Z; Xiang Y; Zheng P; Huang G; Li X; Liao Y; Hagopian WA; Wang CY; Zhou Z
J Clin Endocrinol Metab; 2016 Apr; 101(4):1693-700. PubMed ID: 26866570
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive human leukocyte antigen genotyping of patients with type 1 diabetes mellitus in Taiwan.
Tung YC; Fann CS; Chang CC; Chu CC; Yang WS; Hwu WL; Chen PL; Tsai WY
Pediatr Diabetes; 2018 Jun; 19(4):699-706. PubMed ID: 29383806
[TBL] [Abstract][Full Text] [Related]
14. Association of HLA-DR-DQ alleles, haplotypes, and diplotypes with type 1 diabetes in Saudis.
Eltayeb-Elsheikh N; Khalil E; Mubasher M; AlJurayyan A; AlHarthi H; Omer WH; Elghazali I; Sherbeeni SM; Alghofely MA; Ilonen J; Elghazali G
Diabetes Metab Res Rev; 2020 Nov; 36(8):e3345. PubMed ID: 32418312
[TBL] [Abstract][Full Text] [Related]
15. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
[TBL] [Abstract][Full Text] [Related]
16. Diverse human leukocyte antigen association of type 1 diabetes in north India.
Kumar N; Mehra NK; Kanga U; Kaur G; Tandon N; Chuzho N; Mishra G; Neolia SC
J Diabetes; 2019 Sep; 11(9):719-728. PubMed ID: 30614662
[TBL] [Abstract][Full Text] [Related]
17. Human Leukocyte Antigen class II polymorphisms among Croatian patients with type 1 diabetes and autoimmune polyglandular syndrome type 3 variant.
Grubic Z; Rojnic Putarek N; Maskalan M; Zunec R; Stingl Jankovic K; Burek Kamenaric M; Knezevic-Cuca J; Spehar Uroic A; Dumic M
Gene; 2018 Oct; 674():93-97. PubMed ID: 29958949
[TBL] [Abstract][Full Text] [Related]
18. Family-based association of HLA-DRB1 and DQB1 alleles and haplotypes in a group of Iranian Type 1 diabetes children.
Shirizadeh A; Razavi Z; Saeedi V; Faradmal J; Roshanaei G; Hajilooi M; Morahan G; Solgi G
HLA; 2024 Apr; 103(4):e15446. PubMed ID: 38575369
[TBL] [Abstract][Full Text] [Related]
19. Association of HLA-DR/DQ alleles and haplotypes with nephrotic syndrome.
Ramanathan AS; Senguttuvan P; Chinniah R; Vijayan M; Thirunavukkarasu M; Raju K; Mani D; Ravi PM; Rajendran P; Krishnan JI; Karuppiah B
Nephrology (Carlton); 2016 Sep; 21(9):745-52. PubMed ID: 26566811
[TBL] [Abstract][Full Text] [Related]
20. Association of HLA-DRB1 and -DQB1 alleles with type 1 (autoimmune) diabetes in African Arabs: systematic review and meta-analysis.
Hajjej A; Almawi WY; Stayoussef M; Arnaiz-Villena A; Hattab L; Hmida S
Immunol Invest; 2019 Feb; 48(2):130-146. PubMed ID: 30004835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
